Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


21.08.2017

4 AJR Am J Roentgenol
1 Am J Gastroenterol
1 Am J Pathol
1 Biochem Biophys Res Commun
2 Dig Dis Sci
1 Gastroenterology
1 Gastrointest Endosc
3 Hepatology
1 J Comput Assist Tomogr
5 J Hepatol
1 J Pediatr
2 Lancet Gastroenterol Hepatol
17 PLoS One
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. PARK HJ, Kim JH, Choi SY, Lee ES, et al
    Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings.
    AJR Am J Roentgenol. 2017 Aug 16:W1-W10. doi: 10.2214/AJR.16.17398.
    PubMed     Text format     Abstract available

  2. CANELLAS R, Mehrkhani F, Patino M, Kambadakone A, et al
    Characterization of Portal Vein Thrombosis (Neoplastic Versus Bland) on CT Images Using Software-Based Texture Analysis and Thrombus Density (Hounsfield Units).
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available

  3. CHEN HJ, Liu PF, Chen QF, Shi HB, et al
    Brain Microstructural Abnormalities in Patients With Cirrhosis Without Overt Hepatic Encephalopathy: A Voxel-Based Diffusion Kurtosis Imaging Study.
    AJR Am J Roentgenol. 2017 Aug 16:1-8. doi: 10.2214/AJR.17.17827.
    PubMed     Text format     Abstract available

  4. HAN NY, Park BJ, Yang KS, Kim MJ, et al
    Hepatic Parenchymal Heterogeneity as a Marker for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome: Correlation With Treatment Response of Colorectal Cancer Liver Metastases.
    AJR Am J Roentgenol. 2017 Aug 16:1-7. doi: 10.2214/AJR.16.17528.
    PubMed     Text format     Abstract available


    Am J Gastroenterol

  5. LIU J, Ghaziani TT, Wolf JL
    Acute Fatty Liver Disease of Pregnancy: Updates in Pathogenesis, Diagnosis, and Management.
    Am J Gastroenterol. 2017;112:838-846.
    PubMed     Text format     Abstract available


    Am J Pathol

  6. PULIGA E, Min Q, Tao J, Zhang R, et al
    Thyroid hormone receptor-beta agonist GC-1 inhibits Met-beta-catenin driven hepatocellular cancer.
    Am J Pathol. 2017 Aug 11. pii: S0002-9440(17)30403.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  7. MELENDEZ QM, Wooten CJ, Lopez D
    Atorvastatin and lovastatin, but not pravastatin, increased cellular complex formation between PCSK9 and the LDL receptor in human hepatocyte-like C3A cells.
    Biochem Biophys Res Commun. 2017 Aug 9. pii: S0006-291X(17)31571.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  8. KIM JK, Kim HD, Jun MJ, Yun SC, et al
    Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Aug 16. doi: 10.1007/s10620-017-4708.
    PubMed     Text format     Abstract available

  9. XU H, Xiong J, Xu J, Li S, et al
    Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl4-Induced Cirrhotic Rats.
    Dig Dis Sci. 2017 Aug 16. doi: 10.1007/s10620-017-4704.
    PubMed     Text format     Abstract available


    Gastroenterology

  10. WEILER SME, Pinna F, Wolf T, Lutz T, et al
    Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Gastroenterology. 2017;152:2037-2051.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  11. HUDSON C, Fontenot E, Landreneau S
    Gastric Antral Vascular Ectasia Presents as a Polypoid Mass in a patient with cirrhosis.
    Gastrointest Endosc. 2017 Aug 10. pii: S0016-5107(17)32171.
    PubMed     Text format    


    Hepatology

  12. LIN YH, Wu MH, Huang YH, Yeh CT, et al
    Taurine upregulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma.
    Hepatology. 2017 Aug 12. doi: 10.1002/hep.29462.
    PubMed     Text format     Abstract available

  13. HALGAND B, Desterke C, Riviere L, Fallot G, et al
    Hepatitis B virus pregenomic RNA in hepatocellular carcinoma: A nosological and prognostic determinant.
    Hepatology. 2017 Aug 12. doi: 10.1002/hep.29463.
    PubMed     Text format     Abstract available

  14. DE HAAS RJ, Lim C, Bhangui P, Salloum C, et al
    Curative Salvage Liver Transplantation in Cirrhotic patients with Hepatocellular Carcinoma: An intention-to-treat analysis.
    Hepatology. 2017 Aug 14. doi: 10.1002/hep.29468.
    PubMed     Text format     Abstract available


    J Comput Assist Tomogr

  15. CHERNYAK V, Flusberg M, Law A, Kobi M, et al
    Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features.
    J Comput Assist Tomogr. 2017 Aug 12. doi: 10.1097/RCT.0000000000000642.
    PubMed     Text format     Abstract available


    J Hepatol

  16. WAZIRY R, Hajarizadeh B, Grebely J, Amin J, et al
    Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression.
    J Hepatol. 2017 Aug 9. pii: S0168-8278(17)32199.
    PubMed     Text format     Abstract available

  17. DONG YANG J, Leise MD
    Reply to " Interferon-free therapy of hepatitis C during wait list and post transplant risk of hepatocellular carcinoma recurrence".
    J Hepatol. 2017 Aug 8. pii: S0168-8278(17)32201.
    PubMed     Text format    

  18. MAJUMDAR A, Bailey M, Kemp WM, Bellomo R, et al
    Declining mortality in critically ill patients with cirrhosis in Australia and New Zealand between 2000 and 2015.
    J Hepatol. 2017 Aug 9. pii: S0168-8278(17)32198.
    PubMed     Text format     Abstract available

  19. DONATO MF, Invernizzi F, Rossi G, Iavarone M, et al
    Interferon-free therapy of hepatitis C during wait list and post-transplant risk of hepatocellular carcinoma recurrence.
    J Hepatol. 2017 Aug 10. pii: S0168-8278(17)32200.
    PubMed     Text format    

  20. REBOUISSOU S, Zucman-Rossi J, Moreau R, Qiu Z, et al
    Note of caution: contaminations of hepatocellular cell lines.
    J Hepatol. 2017 Aug 11. pii: S0168-8278(17)32206.
    PubMed     Text format    


    J Pediatr

  21. NEWTON KP, Feldman HS, Chambers CD, Wilson L, et al
    Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children.
    J Pediatr. 2017 Mar 30. pii: S0022-3476(17)30356.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  22. GANE EJ, Pianko S, Roberts SK, Thompson AJ, et al
    Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-C
    Lancet Gastroenterol Hepatol. 2017 Aug 9. pii: S2468-1253(17)30159.
    PubMed     Text format     Abstract available

  23. LAWITZ E, Buti M, Vierling JM, Almasio PL, et al
    Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST
    Lancet Gastroenterol Hepatol. 2017 Aug 9. pii: S2468-1253(17)30163.
    PubMed     Text format     Abstract available


    PLoS One

  24. WERNLY B, Lichtenauer M, Franz M, Kabisch B, et al
    Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
    PLoS One. 2017;12:e0170987.
    PubMed     Text format     Abstract available

  25. SALDANA RS, Schrem H, Barthold M, Kaltenborn A, et al
    Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List Patients.
    PLoS One. 2017;12:e0170499.
    PubMed     Text format     Abstract available

  26. YOO JE, Kim YJ, Rhee H, Kim H, et al
    Progressive Enrichment of Stemness Features and Tumor Stromal Alterations in Multistep Hepatocarcinogenesis.
    PLoS One. 2017;12:e0170465.
    PubMed     Text format     Abstract available

  27. LEE DH, Lee JH, Jung YJ, Gim J, et al
    Validation of a Modified Child-Turcotte-Pugh Classification System Utilizing Insulin-Like Growth Factor-1 for Patients with Hepatocellular Carcinoma in an HBV Endemic Area.
    PLoS One. 2017;12:e0170394.
    PubMed     Text format     Abstract available

  28. GAO W, Zhao J, Gao Z, Li H, et al
    Synergistic Interaction of Light Alcohol Administration in the Presence of Mild Iron Overload in a Mouse Model of Liver Injury: Involvement of Triosephosphate Isomerase Nitration and Inactivation.
    PLoS One. 2017;12:e0170350.
    PubMed     Text format     Abstract available

  29. LEE LH, Hwang JI, Cheng YC, Wu CY, et al
    Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.
    PLoS One. 2017;12:e0169655.
    PubMed     Text format     Abstract available

  30. LU M, Zessin AS, Glover W, Hsu DS, et al
    Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis.
    PLoS One. 2017;12:e0169439.
    PubMed     Text format     Abstract available

  31. ZHANG BB, Yan C, Fang F, Du Y, et al
    Increased hepatic Th2 and Treg subsets are associated with biliary fibrosis in different strains of mice caused by Clonorchis sinensis.
    PLoS One. 2017;12:e0171005.
    PubMed     Text format     Abstract available

  32. LI Q, Wang Y, Ma T, Lv Y, et al
    Clinical outcomes of patients with and without diabetes mellitus after hepatectomy: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0171129.
    PubMed     Text format     Abstract available

  33. BORGATTI A, Winter AL, Stuebner K, Scott R, et al
    Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.
    PLoS One. 2017;12:e0172651.
    PubMed     Text format     Abstract available

  34. SHEU MJ, Hsieh MJ, Chou YE, Wang PH, et al
    Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma.
    PLoS One. 2017;12:e0172506.
    PubMed     Text format     Abstract available

  35. HOLLENBACH M, Thonig A, Pohl S, Ripoll C, et al
    Expression of glyoxalase-I is reduced in cirrhotic livers: A possible mechanism in the development of cirrhosis.
    PLoS One. 2017;12:e0171260.
    PubMed     Text format     Abstract available

  36. SOTHMANN T, Gauer T, Werner R
    4D dose simulation in volumetric arc therapy: Accuracy and affecting parameters.
    PLoS One. 2017;12:e0172810.
    PubMed     Text format     Abstract available

  37. JIN F, Wan C, Li W, Yao L, et al
    Formononetin protects against acetaminophen-induced hepatotoxicity through enhanced NRF2 activity.
    PLoS One. 2017;12:e0170900.
    PubMed     Text format     Abstract available

  38. CANNITO S, Morello E, Bocca C, Foglia B, et al
    Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis.
    PLoS One. 2017;12:e0172575.
    PubMed     Text format     Abstract available

  39. KARAJAMAKI AJ, Kettunen O, Lepojarvi S, Koivurova OP, et al
    Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.
    PLoS One. 2017;12:e0173855.
    PubMed     Text format     Abstract available

  40. PELUSI S, Petta S, Rosso C, Borroni V, et al
    Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease.
    PLoS One. 2016;11:e0163069.
    PubMed     Text format     Abstract available


    Transplantation

  41. CHENG XS, Stedman MR, Chertow GM, Kim WR, et al
    Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation.
    Transplantation. 2017;101:1111-1119.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: